SCHEMBL22282131

SCHEMBL22282131

CNc1c2c(cc3c1CCC3=O)CCC2

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 9/20 0.40
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
PRKCI P41743 1/20 0.38
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
BAZ2B Q9UIF8 1/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP2A6 P11509 1/20 0.34
ALDH1A1 P00352 1/20 0.34
PARP1 P09874 1/20 0.33
PBRM1 Q86U86 1/20 0.33
CDC25B P30305 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20692248 0.80 NLRP3 (0.44) NLRP3ATMSMN1; SMN2ALDH1A1
SCHEMBL19505705 0.80 NLRP3 (0.46) NLRP3ATMSMN1; SMN2ALDH1A1
SCHEMBL26590829 0.78 NLRP3 (0.45) NLRP3ATMSMN1; SMN2ALDH1A1
SCHEMBL22280260 0.77 MEN1 (0.41) NLRP3MAOAMAOBPRKCIMEN1
SCHEMBL22013010 0.77 NLRP3 (0.43) NLRP3ATMSMN1; SMN2ALDH1A1
SCHEMBL19476121 0.76 NLRP3 (0.42) NLRP3MEN1KMT2AATMSMN1; SMN2
SCHEMBL18007624 0.74 MEN1 (0.41) NLRP3MAOAMAOBPRKCIMEN1
SCHEMBL18393609 0.74 MAPK1 (0.41) NLRP3MAOAMAOBPRKCIMEN1
SCHEMBL22011681 0.74 MEN1 (0.41) NLRP3MAOAMAOBPRKCIMEN1
SCHEMBL24294871 0.73 MEN1 (0.38) NLRP3MAOAMAOBPRKCIMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020154499-A1 SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-07-30 WO disclosed